CIDRI-Africa

Image of scientist holding up a Petri dish

Supporting Excellence

The Wellcome Centre for Infectious Diseases Research in Africa fosters investigator-led approaches via the overarching scientific objective of combatting infection, especially HIV-1 and tuberculosis, through clinical and laboratory research.

Macrophages infected with M. tuberculosis; image by Dr Suraj Parihar

Basic Science

Our Basic Science Platform provides the laboratory infrastructure and technical support to ensure the safe handling of infectious material.

Subgraph of the ANIMA network for dataset HIVsetB

Biomedical Data Integration

We work with multidimensional clinical and scientific data at the molecular, cellular, clinical and population levels.

Image of a researcher and study participant reading an informed consent document

Clinical Research

CIDRI-Africa supports clinical studies in the community at our facility at Site B in Khayelitsha.

For information on South Africa's response to COVID-19 please visit the COVID-19 Corona Virus South African Resource Portal.

News

Saturday, 4 July 2020

COVID-19’s interaction with HIV and TB investigated

The HIATUS study, a research programme being launched by the Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa) at the University of Cape Town (UCT), will investigate the interaction between the COVID-19 pandemic and common endemic infectious diseases in the South African context.

Publication Date:

Tue, 02 Jun 2020 - 15:45

Icon made from <a href="http://www.onlinewebfonts.com/icon">Icon Fonts</a> is licensed by CC BY 3.0

Wellcome award to CIDRI-Africa to enrich Public Engagement activities

The grant will enable CIDRI-Africa to further deepen our researcher community as public engagement champions, engage local communities and stakeholders, and raise awareness of research results.

Publication Date:

Tue, 12 May 2020 - 10:45